{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:25:15Z","timestamp":1793395515774,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-025-03097-z","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T02:48:46Z","timestamp":1743907726000},"page":"556-565","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of unfractionated heparin dosing using an antifactor-Xa-based protocol in non-obese vs. obese patients for acute venous thromboembolism"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8743-7092","authenticated-orcid":false,"given":"Trenton","family":"Flanagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uyen-Thi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2163-7062","authenticated-orcid":false,"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1149-5937","authenticated-orcid":false,"given":"Vivek","family":"Kataria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"key":"3097_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.10.014","author":"EJ Bell","year":"2016","unstructured":"Bell EJ, Lutsey PL, Basu S et al (2016) Lifetime risk of venous thromboembolism in two cohort studies. Am J Med. https:\/\/doi.org\/10.1016\/j.amjmed.2015.10.014","journal-title":"Am J Med"},{"issue":"1","key":"3097_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2010.01.057","volume":"56","author":"SZ Goldhaber","year":"2010","unstructured":"Goldhaber SZ (2010) Risk factors for venous thromboembolism. J Am Coll Cardiol 56(1):1\u20137. https:\/\/doi.org\/10.1016\/j.jacc.2010.01.057","journal-title":"J Am Coll Cardiol"},{"key":"3097_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.thromres.2016.06.033","volume":"145","author":"MK Puurunen","year":"2016","unstructured":"Puurunen MK, Gona PN, Larson MG, Murabito JM, Magnani JW, O\u2019Donnell CJ (2016) Epidemiology of venous thromboembolism in the Framingham Heart Study. Thromb Res 145:27\u201333. https:\/\/doi.org\/10.1016\/j.thromres.2016.06.033","journal-title":"Thromb Res"},{"issue":"15","key":"3097_CR4","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1001\/archinte.168.15.1678","volume":"168","author":"S Eichinger","year":"2008","unstructured":"Eichinger S, Hron G, Bialonczyk C et al (2008) Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch Intern Med 168(15):1678\u20131683. https:\/\/doi.org\/10.1001\/archinte.168.15.1678","journal-title":"Arch Intern Med"},{"issue":"16","key":"3097_CR5","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1001\/jama.2023.19201","volume":"330","author":"E Harris","year":"2023","unstructured":"Harris E (2023) US obesity prevalence surged over the past decade. JAMA 330(16):1515. https:\/\/doi.org\/10.1001\/jama.2023.19201","journal-title":"JAMA"},{"issue":"3","key":"3097_CR6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1592\/phco.30.3.324","volume":"30","author":"AE Myzienski","year":"2010","unstructured":"Myzienski AE, Lutz MF, Smythe MA (2010) Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literature. Pharmacotherapy 30(3):324. https:\/\/doi.org\/10.1592\/phco.30.3.324","journal-title":"Pharmacotherapy"},{"issue":"1","key":"3097_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11239-015-1315-2","volume":"41","author":"MA Smythe","year":"2016","unstructured":"Smythe MA, Priziola J, Dobesh PP, Wirth D, Cuker A, Wittkowsky AK (2016) Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism. J Thromb Thrombolysis 41(1):165\u2013186. https:\/\/doi.org\/10.1007\/s11239-015-1315-2","journal-title":"J Thromb Thrombolysis"},{"issue":"2 Suppl","key":"3097_CR8","doi-asserted-by":"publisher","first-page":"e24S","DOI":"10.1378\/chest.11-2291","volume":"141","author":"DA Garcia","year":"2012","unstructured":"Garcia DA, Baglin TP, Weitz JI, Samama MM (2012) Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e24S-e43S. https:\/\/doi.org\/10.1378\/chest.11-2291. ([published correction appears in Chest. 2012;141(5):1369. Dosage error in article text] [published correction appears in Chest. 2013;144(2):721. Dosage error in article text])","journal-title":"Chest"},{"issue":"7\u20138","key":"3097_CR9","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1345\/aph.1P088","volume":"44","author":"JN Riney","year":"2010","unstructured":"Riney JN, Hollands JM, Smith JR, Deal EN (2010) Identifying optimal initial infusion rates for unfractionated heparin in morbidly obese patients. Ann Pharmacother 44(7\u20138):1141\u20131151. https:\/\/doi.org\/10.1345\/aph.1P088","journal-title":"Ann Pharmacother"},{"issue":"4","key":"3097_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s11239-016-1466-9","volume":"43","author":"M Isherwood","year":"2017","unstructured":"Isherwood M, Murphy ML, Bingham AL, Siemianowski LA, Hunter K, Hollands JM (2017) Evaluation of safety and effectiveness of standardized antifactor Xa-based unfractionated heparin protocols in obese versus non-obese patients. J Thromb Thrombolysis 43(4):476\u2013483. https:\/\/doi.org\/10.1007\/s11239-016-1466-9","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"3097_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/1358863X19875813","volume":"25","author":"JA Shlensky","year":"2020","unstructured":"Shlensky JA, Thurber KM, O\u2019Meara JG et al (2020) Unfractionated heparin infusion for treatment of venous thromboembolism based on actual body weight without dose capping. Vasc Med 25(1):47\u201354. https:\/\/doi.org\/10.1177\/1358863X19875813","journal-title":"Vasc Med"},{"issue":"6","key":"3097_CR12","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/j.1875-9114.2011.01049.x","volume":"32","author":"JW Vandiver","year":"2012","unstructured":"Vandiver JW, Vondracek TG (2012) Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin. Pharmacotherapy 32(6):546\u2013558. https:\/\/doi.org\/10.1002\/j.1875-9114.2011.01049.x","journal-title":"Pharmacotherapy"},{"issue":"7\u20138","key":"3097_CR13","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1345\/aph.1Q161","volume":"45","author":"DJ Guervil","year":"2011","unstructured":"Guervil DJ, Rosenberg AF, Winterstein AG, Harris NS, Johns TE, Zumberg MS (2011) Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion. Ann Pharmacother 45(7\u20138):861\u2013868. https:\/\/doi.org\/10.1345\/aph.1Q161","journal-title":"Ann Pharmacother"},{"issue":"11","key":"3097_CR14","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1310\/hpj4311-895","volume":"43","author":"BM Dee","year":"2008","unstructured":"Dee BM, Thomas ML (2008) Safety and efficacy of a high-intensity, weight-based, intravenous heparin protocol revision in patients who are obese. Hosp Pharm 43(11):895\u2013902","journal-title":"Hosp Pharm"},{"issue":"4","key":"3097_CR15","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3(4):692\u2013694. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01204.x","journal-title":"J Thromb Haemost"},{"issue":"1","key":"3097_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s13054-017-1872-1","volume":"21","author":"A Perel","year":"2017","unstructured":"Perel A (2017) Iatrogenic hemodilution: a possible cause for avoidable blood transfusions? Crit Care 21(1):291. https:\/\/doi.org\/10.1186\/s13054-017-1872-1","journal-title":"Crit Care"},{"issue":"2","key":"3097_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jcrc.2014.11.020","volume":"30","author":"EM Hohner","year":"2015","unstructured":"Hohner EM, Kruer RM, Gilmore VT, Streiff M, Gibbs H (2015) Unfractionated heparin dosing for therapeutic anticoagulation in critically ill obese adults. J Crit Care 30(2):395\u2013399. https:\/\/doi.org\/10.1016\/j.jcrc.2014.11.020","journal-title":"J Crit Care"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03097-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-025-03097-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03097-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T02:11:45Z","timestamp":1746065505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-025-03097-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":17,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["3097"],"URL":"https:\/\/doi.org\/10.1007\/s11239-025-03097-z","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,5]]},"assertion":[{"value":"27 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article. The authors did not receive support from any organization for the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical Standards. Approval was obtained from the Institutional Review Board of the Baylor Research Institute.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal participants"}}]}}